Bio
Mintu Turakhia M.D. M.A.S. is an internationally renowned cardiologist and cardiac electrophysiologist, outcomes researcher and clinical trialist, executive, and leader in digital health, AI, and heart rhythm care.
In 2022, Dr. Turakhia took a leave of absence from his tenured Professor of Medicine rule to serve as the Chief Medical Officer, Chief Scientific Officer and Executive Vice President of Product (now Advanced Technologies) at iRhythm Technologies, Inc. At iRhythm, he has a large operational span, leading Product Management, Advanced Technologies, Medical Affairs, Scientific Affairs, Medical Safety, and clinical oversight of the Independent Diagnostic Testing Facility. At iRhythm, he helped to grow the company’s revenue 20+% YOY for three consecutive years, led the company’s largest ever product launches of award-winning hardware, apps, and new services, and overhauled to scientific function to create best-in-class evidence to reshape guidelines and payer policies to adopt iRhythm’s core products as first-line diagnostics. He architected the company’s new 7-year product roadmap and scaled programs for new AI features, multi-sensor hardware, population health management, clinical trial services verticals, and global expansion in 7 new European and Asian markets — all while revamping the scientific program, building a clinical trials unit and clinical data warehouse, and generating the largest ever scientific output in the company's history.
At Stanford, he was the Founding Director of the Stanford Center for Digital Health, started in 2015 and the first of its kind, where he led a large multidisciplinary program on clinical research, education, technology incubation, and international thought leadership on digital health, wearables, and AI, with an emphasis on cardiovascular disease and heart rhythm disorders. He has led several large-scale trials of digital health tools and wearables for heart disease, including as co-principal investigator of the landmark Apple Heart Study, enrolling over 400,000 participants, and published in the New England Journal of Medicine (NEJM). For 14 years, he served as Chief of Cardiac Electrophysiology at the VA Palo Alto Health Care System, where he developed a best-in-class, high volume arrhythmia care program.
Dr. Turakhia completed his bachelor’s degree at the University of California (UC) Berkeley, MD and master’s degrees at UCSF, and clinical training at Harvard’s Brigham & Women’s Hospital and UCSF. Trained in computer science, medicine, biostatistics, and research, he has over 25 years of experience in patient care, health economics and outcomes research, clinical trials, data science and AI, medical device regulation, and the creation and commercialization of digital health products — having created PPG- and accelerometer-based wearables for clinical research while in college.
Over the last 20 years, he has held several dozen leadership roles in the Heart Rhythm Society, American Heart Association, American College of Cardiology, and European Society of Cardiology. He was the Founding Chair of HRX 2022, a new clinical and industry meeting by dedicated to cardiovascular diagnostics. An elected member of the American Society of Clinical Investigation, Dr. Turakhia has authored over 300 publications and has received over $50 million in research funding. In 2022, he received the Rock Health Digital Health Luminary Award. In academic and industry roles, he has led or worked with teams to build and launch the first FDA-cleared deep learning AI tool for ECG interpretation, best-in-class connected products for cardiac monitoring, remote patient monitoring platforms, and electronic health record AI knowledge extraction tools. During his tenure, he served as an advisor, consultant, board memberm or co-founder to over 30 medical device and health technology companies.
